Nagi Bioscience: Swiss startup Nagi Bioscience raises €1.6 million to replace animal testing

Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closing of a €1.6 million seed financing round. Investors in the round include the leading Swiss venture capital platform investiere, Zürcher Kantonalbank, NEST pension fund and private investors from Switzerland and the [...]